The largest database of trusted experimental protocols

Granzyme b pe

Manufactured by BD
Sourced in United States

Granzyme B-PE is a laboratory reagent used for the detection and measurement of Granzyme B, a protein involved in the process of apoptosis. It consists of the Granzyme B protein conjugated to the fluorescent dye Phycoerythrin (PE), which allows for the identification and quantification of Granzyme B-positive cells through flow cytometry or other fluorescence-based techniques.

Automatically generated - may contain errors

7 protocols using granzyme b pe

1

Flow Cytometric Analysis of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cultures were collected, washed, incubated for 15 min with mouse mAbs against human CD3-PerCP, CD56-FITC, or PE, CD69-APC, CD16-PE (BD Biosciences, USA), and NKG2D-PE (BioLegend, USA). NK cells were incubated with CD158a-PE and CD158b-PE (BD Pharmingen, USA), CIK cells were incubated with CD4-PE and CD8-APC (BD Biosciences) and γδ T cells were incubated with Vγ9-FITC (BD Pharmingen), CD4-PE, and CD8-APC. Isotype-matched antibodies were used as controls. Perforin and granzyme B detection was performed according to the BD Cytofix/Cytoperm™ Kit manual (BD Biosciences). Briefly, NK, CIK, and γδ T cells were harvested and adjusted to 1 × 106 cells/mL in RPMI-1640 medium containing 10 % fetal calf serum, and incubated 0.1 % GolgiStop (BD Biosciences) for 4 h. After pre-incubation with 10 % normal human serum, cells were stained with mAbs to identify NK (CD3CD56+), CIK (CD3+CD56+), and γδ T cells (CD3+Vγ9+), followed by intracellular staining for perforin-PE and granzyme B-PE (BD Pharmingen), and the corresponding isotype antibodies to determine intracellular cytokine levels.
Flow cytometry data acquisition was performed on a BD FACS Calibur (BD Biosciences) with Cell Quest Pro software. Analysis was performed with FlowJo software (Tree Star, USA).
+ Open protocol
+ Expand
2

Characterization of Immune Subsets and PD-L1 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
CAR expression was detected using biotinylated soluble human PD-L1 protein (Biosystems Acro) as a primary stain followed by PE-conjugated streptavidin (BD Biosciences) as the secondary stain. The following antibodies and stains were also used: CD56-APC (BD Biosciences), CD16-BV510 (BD), granzyme B-PE (BD Biosciences), perforin-BV421 (BD Biosciences), PD-L1-PE (BD Biosciences), and LIVE/DEAD fixable blue dead stain (Thermo Fisher). To identify the 135 immune subsets in the PBMCs (online supplementary table S1), methodology and gating strategies that have been previously described21 22 (link) were used with slight modifications. Antibody panels were slightly modified (online supplementary table S2). Flow cytometry was performed on BD LSRFortessa or BD FACSVerse (BD Biosciences) and analyzed using FlowJo V.9.7.6 or V.10.5.3 (TreeStar). FACS of PD-L1high and PD-L1low MDA-MB-231 was performed using the MA900 (Sony) sorter.
+ Open protocol
+ Expand
3

Comprehensive T-cell Immunophenotyping Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry antibodies used for surface marker staining are listed as follows. Antibodies from BD Biosciences include: CD3‐BUV395 (Clone UCHT1; cat #563 546), CD4‐BV786 (Clone SK3; cat #563 877) and CD8‐PE‐Cy7 (Clone SK1; cat #335 787). Antibodies from Biolegend include: CD3‐FITC (Clone UCHT1; cat #300 406), CCR7‐PE (Clone G043H7; cat #353 204), CD45RA‐APC (Clone HI100; cat #304 112), CD45RO‐Pacific Blue (Clone UCHL1; cat #304 215),CD27‐Pacific Blue (Clone M‐T271; cat #356 413), CD28‐FITC (Clone CD28.2; cat #302 906), CD28‐PE (Clone CD28.2; cat #302 907), CD95‐FITC (Clone DX2; cat #305 605), CD127‐Brilliant Violet 785 (Clone A019D5; cat #351 329), TIM‐3‐Pacific Blue (Clone F38‐2E2; cat #345 041), CD57‐FITC (Clone HNK‐1; cat #359 603), LAG‐3‐Brilliant Violet 785 (Clone 11C3C65; cat #369 321) and human TruStain FcX reagent (Cat #422 302). Antibodies for intracellular staining include granzyme B‐PE (BD Biosciences, GB11; cat #561 142), IFN‐γ‐FITC (Miltenyi Biotec, cat #130‐090‐433), IL‐2‐PE (Miltenyi Biotec, cat #130‐090‐487) and TNF‐α‐APC (Miltenyi Biotec, cat #130‐091‐267).
+ Open protocol
+ Expand
4

Comprehensive Cytokine Profiling of Stimulated PBMC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples (heparin) were diluted 1:1 with RPMI and stimulated with 40 nM PMA and 2 nM Ca2+ ionophore A23187 in the presence of 3 µM brefeldin A (all Sigma) for 4 h. Subsequently, red blood cells were lysed with ammonium chloride. The remaining cells were treated with Fix/Perm reagents A and B (Invitrogen) and stained with the following antibodies: CD3-eFluor 605, CD4-eFluor450, interleukin (IL)-17-AF488, Perforin-FITC (eBioscience), CD161-APC (Miltenyi), CD8-APC-H7, Granzyme-B-PE (BD), IFN-γ-PerCP-Cy5.5, IL-4-PE, and TNF-α-PerCP-Cy5.5 (Biolegend). Samples were measured on an LSR-II flow cytometer (BD) and analyzed with Kaluza Analysis Software (Beckman Coulter).
+ Open protocol
+ Expand
5

Multiparameter Phenotyping of Lymphocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Four-color staining of lymphocytes was performed to determine the frequency and phenotype of lymphocytes among freshly isolated PBMCs from either healthy donors or patients as well as among TILs from patients. The following monoclonal antibodies (mAbs) were used: CD19-PerCP (#302228), CD56-APC (#555518), CD3-FITC (#555332), CD8-PerCP (#340693), CD8-FITC (#555366), CD45RA-FITC (#555488), CD38-FITC (#555459), CD38-APC (#555462), HLA-DR-APC (#559866), HLA-DR-BV421 (#307636), CCR5-FITC (#555992), CCR5-PE (#555993), TNFR2-PE (#FAB226P), IFN-γ-PE (#559326), IL-2-PE (#559334), PD-1-PE (#129969), Tim-3-PE (#123109), CCR7-PE-Cy7 (#557648), T-bet-PerCP-Cy5.5 (#561316), CD107a-PE (#555801), and Granzyme B-PE (#561142) (BD Biosciences, USA). Lymphocytes were first stained at 4°C for 1 h with mAbs to cell surface markers. Each sample contained at least 2 × 106 lymphocytes isolated from PBMCs or TILs. Expression of surface antigens was analyzed using a dual-laser fluorescence-activated cell sorting cytofluorimeter (FACSCalibur; FACSCantoTMII; BD Biosciences, USA) employing Cell-Quest software (BD Biosciences, USA).
+ Open protocol
+ Expand
6

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies from BD Biosciences (Franklin Lakes, NJ) were used for staining: CD8-FITC (53.67), CD8-APC (KT15), Foxp3-PE (FJK-16s), CD3-AF700 (17A2), CD44-PerCP-Cy5.5 (IM7), CD4-FITC (RM4– 5), CD62L-BV421 (MEL-14), CD25-APC (PC61), Ki67-PE-Cy7 (SolA15), CTLA-4-PE (UC10–4F10–11), PD-1-BV421 (RMP1–30), granzyme B-PE (NGZB), OX40-BV711 (OX86), GITR-BV510 (DTA-1). MHC class I-restricted (H2-Db) PE-labeled CEA-tetramer (sequence: EAQNTTYL) was purchased from MBL International Corporation (Woburn, MA). Live/Dead fixable aqua stain and transcription factor staining buffer set were purchased from Thermo Fisher (Waltham, MA). Flow cytometry was performed on BD LSRFortessa or BD FACSVerse (BD Biosciences) and analyzed using FlowJo v.9.7.6 or v.10.5.3 (TreeStar). Cell viability was examined using trypan blue staining prior to data acquisition. Live cells were gated via forward and side scatter. Isotype control staining was <5% for all samples analyzed.
+ Open protocol
+ Expand
7

Multiparametric Immune Profiling by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphocyte surface phenotypes were evaluated by flow cytometry on cryopreserved PBMCs: CD4-APC-H7, CD8-PErCP-Cy5.5, CD38-PCY-7, HLA-DR-BV421, CD45RA-APC-H7, CCR7- PECy5, LIVE/DEAD-V500, Granzyme B-PE, Perforin-FITC, CD16-APC, CD14-BV421, CD56-PE (BD Biosciences, San Jose, CA, USA) and CD19-PercPVio700, CD80-APC (Miltenyi Biotec, Bergisch Gladbach, Germany). Combinations used were: CD4/CD8/CD38/HLA-DR (T-cell activation), CD14/CD16 (monocyte), CD16/CD56/CD3 (NK cells), CD11c/CD3 (DC), CD3/CD19/CD80 (B-cell activation), CD4/CD8/CD45RA/CCR7 (T-cell maturation). T-cell subsets were defined as naïve CCR (C-C chemokine receptor)7+CD45RA+, central memory (CM) CCR7+CD45RA−, effector memory (EM) CCR7−CD45RA−, terminally differentiated (TD) CCR7−CD45RA+. T follicular helper (Tfh) CD4+CxCR5+CD45RA+, T helper 17-like (Th17) CD4+CCR6+CD161+, T regulatory-like (Treg) CD4+CD127-CD25+. Briefly, 1 × 106 PBMCs were stained with the appropriate antibodies for 20 min at 4°C in the dark and then washed and acquired using FACSVerse™ cytometer (BD Biosciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!